Key result
In 18 sudden cardiac death cases, a panel of multiple immunohistochemical markers provided evidence of early myocardial ischemia when no macroscopic evidence of necrosis was available.
Why the study?
Does a panel of immunohistochemical markers (C5b-9, fibronectin, myoglobin, cardiac troponin) improve the postmortem detection of early myocardial ischemia in sudden cardiac death cases?
Observational (n=18)
Does a panel of immunohistochemical markers (C5b-9, fibronectin, myoglobin, cardiac troponin) improve the postmortem detection of early myocardial ischemia in sudden cardiac death cases?
A multi-marker immunohistochemical panel can aid forensic pathologists in diagnosing early myocardial infarction in sudden cardiac death cases where standard histology is unrevealing.
Answers are grounded in this paper and cite their sources.
May aid forensic detection of early ischemia in select SCD cases; hypothesis-generating and requires validation before wider use.
The postmortem diagnosis of acute myocardial infarction represents a current challenge for forensic pathologists, particularly when death occurs within minutes to a few hours after the ischemic insult. Among the adult population the single most important cause of sudden cardiac death (SCD) is the well-known atherosclerotic coronary artery disease, commonly asymptomatic or unrecognized. The recognition of early myocardial damage using routine hematoxylin and eosin (H&E) staining is possible only if death has occurred at least 6 hours after the onset of the ischemic injury. The usefulness of immunohistochemical markers to the diagnosis of early myocardial damage has been recently suggested because most of them can be visible even serologically as early as few minutes after the beginning of the symptoms. To evaluate the usefulness of plasma and cellular antigens, their distribution patterns have been studied among a group of 18 SCD cases in which a myocardial ischemia was strongly suspected. For the present study, 4 markers have been selected on the basis of their different diagnostic potential as follows: among the plasma markers the C5b-9 and fibronectin, among the cellular markers the myoglobin and cardiac troponin. The results show that only the study of multiple markers such as those selected can provide enough evidence of myocardial ischemia and/or necrosis, supporting the final diagnosis of SCD. No single immunohistochemical staining is ideal for diagnosing early myocardial ischemia but a set of markers can improve the ability of forensic pathologists to detect ischemic areas when no macroscopic or microscopic evidence of necrosis is available. However, the interpretation of data obtained in each individual cannot be isolated from the overall assessment of the factors (cardiopulmonary resuscitation and/or agonal artifacts) that can affect the expression of each marker.
No takes yet. Share an insight, caveat, or question.
Campobasso et al. (2008) conducted an observational in Sudden cardiac death with suspected myocardial ischemia (n=18). Multiple immunohistochemical markers (C5b-9, fibronectin, myoglobin, cardiac troponin) was evaluated on Detection of early myocardial ischemia and/or necrosis. In 18 sudden cardiac death cases, a panel of multiple immunohistochemical markers provided evidence of early myocardial ischemia when no macroscopic evidence of necrosis was available.
Synapse has enriched 10 related papers. Consider them for comparative context: